Effect of the decision to perform hysteroscopy on asymptomatic patients before undergoing assisted reproduction technologies—a systematic review and meta-analysisAJOG Global Reports at a Glance

OBJECTIVE: Routine hysteroscopic evaluation before assisted reproductive technology treatment is a novel approach with the potential to reduce assisted reproductive technology failure even in the absence of evidence of uterine pathology. Following the publication of several relatively high-quality t...

Full description

Bibliographic Details
Main Authors: Greg J. Marchand, MD, FACS, FICS, FACOG, Ahmed Taher Masoud, MD, Hollie Ulibarri, BS, Julia Parise, BS, Amanda Arroyo, BS, Catherine Coriell, BS, Sydnee Goetz, BS, Carmen Moir, BS, Atley Moberly, BS
Format: Article
Language:English
Published: Elsevier 2023-05-01
Series:AJOG Global Reports
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2666577823000199
_version_ 1827927812510580736
author Greg J. Marchand, MD, FACS, FICS, FACOG
Ahmed Taher Masoud, MD
Hollie Ulibarri, BS
Julia Parise, BS
Amanda Arroyo, BS
Catherine Coriell, BS
Sydnee Goetz, BS
Carmen Moir, BS
Atley Moberly, BS
author_facet Greg J. Marchand, MD, FACS, FICS, FACOG
Ahmed Taher Masoud, MD
Hollie Ulibarri, BS
Julia Parise, BS
Amanda Arroyo, BS
Catherine Coriell, BS
Sydnee Goetz, BS
Carmen Moir, BS
Atley Moberly, BS
author_sort Greg J. Marchand, MD, FACS, FICS, FACOG
collection DOAJ
description OBJECTIVE: Routine hysteroscopic evaluation before assisted reproductive technology treatment is a novel approach with the potential to reduce assisted reproductive technology failure even in the absence of evidence of uterine pathology. Following the publication of several relatively high-quality trials on this topic, we sought to determine if this practice is beneficial. DATA SOURCES: We searched Web of Science, MEDLINE, PubMed, Scopus, Cochrane Library, and ClinicalTrials.gov from each database's inception until May 31, 2022 with our search strategy, attempting to locate all randomized controlled trials assessing the use of hysteroscopy in otherwise asymptomatic women undergoing assisted reproductive technology. STUDY ELIGIBILITY CRITERIA: We included only randomized controlled trials that included at least one of our selected outcomes, and we excluded any studies with suspicion of pathology before the time of hysteroscopy, other than knowledge of the patient's infertility. We included all the aforementioned studies regardless of procedures or modifications performed as a result of hysteroscopic findings. Our initial search yielded 1802 results, which were reduced to 1421 after removal of duplicates. Ultimately, 11 studies were found to meet our criteria and were included in our quantitative synthesis. METHODS: We used ReviewManager software, version 5.4.1 to analyze the data, which we imported after manually gathering from the 11 studies. Continuous and dichotomous outcomes were imported as standard deviations. Pooled analysis was described as a mean difference, relative to 95 % confidence interval in cases of continuous data. Dichotomous outcomes were analyzed using risk ratios and 95% confidence intervals. In homogeneous outcomes, we used a fixed-effects model, and in heterogeneous outcomes we used a random-effects model. RESULTS: Our results showed that hysteroscopy was associated with significant improvement in the clinical pregnancy rate (risk ratio, 1.27 [1.11–1.45]; P<.001). We found no differences between the hysteroscopy group and the control group in live birth rate (risk ratio, 1.26 [0.99–1.59]; P=.06), miscarriage rate (risk ratio, 0.99 [0.81–1.19]; P=.88), fertilization rate (risk ratio, 1.01 [0.93–1.09]; P=.88), incidence of multiple gestations (risk ratio, 1.29 [0.98–1.71]; P=.07), number of embryos transferred (mean difference, 0.04 [−0.18 to 0.26]; P=.73), chemical pregnancy rate (risk ratio, 1.01 [0.86–1.17]; P=.93), and number of oocytes retrieved (mean difference, 0.44 [−0.11 to 0.98]; P=.11). CONCLUSION: We observed an improvement in the clinical pregnancy rate, but no significant improvement in the live birth rate with routine hysteroscopy before assisted reproductive technology treatment. We believe this does not represent sufficient evidence to recommend routine hysteroscopy for otherwise asymptomatic patients before assisted reproductive technology treatment at this time.
first_indexed 2024-03-13T05:58:19Z
format Article
id doaj.art-bf9641eadf79435fa1a103f77ac684ba
institution Directory Open Access Journal
issn 2666-5778
language English
last_indexed 2024-03-13T05:58:19Z
publishDate 2023-05-01
publisher Elsevier
record_format Article
series AJOG Global Reports
spelling doaj.art-bf9641eadf79435fa1a103f77ac684ba2023-06-13T04:12:47ZengElsevierAJOG Global Reports2666-57782023-05-0132100178Effect of the decision to perform hysteroscopy on asymptomatic patients before undergoing assisted reproduction technologies—a systematic review and meta-analysisAJOG Global Reports at a GlanceGreg J. Marchand, MD, FACS, FICS, FACOG0Ahmed Taher Masoud, MD1Hollie Ulibarri, BS2Julia Parise, BS3Amanda Arroyo, BS4Catherine Coriell, BS5Sydnee Goetz, BS6Carmen Moir, BS7Atley Moberly, BS8Faculty of Medicine, Marchand Institute for Minimally Invasive Surgery, Mesa, AZ (Drs Marchand and Masoud, Mses Ulibarri, Parise, and Arroyo, Ms Coriell, and Mses Goetz, Moir, and Moberly); Corresponding author: Greg J. Marchand, MD, FACS, FACOG, FICS.Faculty of Medicine, Fayoum University, Fayoum, Egypt (Dr Masoud).Faculty of Medicine, Marchand Institute for Minimally Invasive Surgery, Mesa, AZ (Drs Marchand and Masoud, Mses Ulibarri, Parise, and Arroyo, Ms Coriell, and Mses Goetz, Moir, and Moberly)Faculty of Medicine, Marchand Institute for Minimally Invasive Surgery, Mesa, AZ (Drs Marchand and Masoud, Mses Ulibarri, Parise, and Arroyo, Ms Coriell, and Mses Goetz, Moir, and Moberly)Faculty of Medicine, Marchand Institute for Minimally Invasive Surgery, Mesa, AZ (Drs Marchand and Masoud, Mses Ulibarri, Parise, and Arroyo, Ms Coriell, and Mses Goetz, Moir, and Moberly)Faculty of Medicine, Marchand Institute for Minimally Invasive Surgery, Mesa, AZ (Drs Marchand and Masoud, Mses Ulibarri, Parise, and Arroyo, Ms Coriell, and Mses Goetz, Moir, and Moberly)Faculty of Medicine, Marchand Institute for Minimally Invasive Surgery, Mesa, AZ (Drs Marchand and Masoud, Mses Ulibarri, Parise, and Arroyo, Ms Coriell, and Mses Goetz, Moir, and Moberly)Faculty of Medicine, Marchand Institute for Minimally Invasive Surgery, Mesa, AZ (Drs Marchand and Masoud, Mses Ulibarri, Parise, and Arroyo, Ms Coriell, and Mses Goetz, Moir, and Moberly)Faculty of Medicine, Marchand Institute for Minimally Invasive Surgery, Mesa, AZ (Drs Marchand and Masoud, Mses Ulibarri, Parise, and Arroyo, Ms Coriell, and Mses Goetz, Moir, and Moberly)OBJECTIVE: Routine hysteroscopic evaluation before assisted reproductive technology treatment is a novel approach with the potential to reduce assisted reproductive technology failure even in the absence of evidence of uterine pathology. Following the publication of several relatively high-quality trials on this topic, we sought to determine if this practice is beneficial. DATA SOURCES: We searched Web of Science, MEDLINE, PubMed, Scopus, Cochrane Library, and ClinicalTrials.gov from each database's inception until May 31, 2022 with our search strategy, attempting to locate all randomized controlled trials assessing the use of hysteroscopy in otherwise asymptomatic women undergoing assisted reproductive technology. STUDY ELIGIBILITY CRITERIA: We included only randomized controlled trials that included at least one of our selected outcomes, and we excluded any studies with suspicion of pathology before the time of hysteroscopy, other than knowledge of the patient's infertility. We included all the aforementioned studies regardless of procedures or modifications performed as a result of hysteroscopic findings. Our initial search yielded 1802 results, which were reduced to 1421 after removal of duplicates. Ultimately, 11 studies were found to meet our criteria and were included in our quantitative synthesis. METHODS: We used ReviewManager software, version 5.4.1 to analyze the data, which we imported after manually gathering from the 11 studies. Continuous and dichotomous outcomes were imported as standard deviations. Pooled analysis was described as a mean difference, relative to 95 % confidence interval in cases of continuous data. Dichotomous outcomes were analyzed using risk ratios and 95% confidence intervals. In homogeneous outcomes, we used a fixed-effects model, and in heterogeneous outcomes we used a random-effects model. RESULTS: Our results showed that hysteroscopy was associated with significant improvement in the clinical pregnancy rate (risk ratio, 1.27 [1.11–1.45]; P<.001). We found no differences between the hysteroscopy group and the control group in live birth rate (risk ratio, 1.26 [0.99–1.59]; P=.06), miscarriage rate (risk ratio, 0.99 [0.81–1.19]; P=.88), fertilization rate (risk ratio, 1.01 [0.93–1.09]; P=.88), incidence of multiple gestations (risk ratio, 1.29 [0.98–1.71]; P=.07), number of embryos transferred (mean difference, 0.04 [−0.18 to 0.26]; P=.73), chemical pregnancy rate (risk ratio, 1.01 [0.86–1.17]; P=.93), and number of oocytes retrieved (mean difference, 0.44 [−0.11 to 0.98]; P=.11). CONCLUSION: We observed an improvement in the clinical pregnancy rate, but no significant improvement in the live birth rate with routine hysteroscopy before assisted reproductive technology treatment. We believe this does not represent sufficient evidence to recommend routine hysteroscopy for otherwise asymptomatic patients before assisted reproductive technology treatment at this time.http://www.sciencedirect.com/science/article/pii/S2666577823000199assisted reproductive technologyhysteroscopyinfertilityin vitro fertilization
spellingShingle Greg J. Marchand, MD, FACS, FICS, FACOG
Ahmed Taher Masoud, MD
Hollie Ulibarri, BS
Julia Parise, BS
Amanda Arroyo, BS
Catherine Coriell, BS
Sydnee Goetz, BS
Carmen Moir, BS
Atley Moberly, BS
Effect of the decision to perform hysteroscopy on asymptomatic patients before undergoing assisted reproduction technologies—a systematic review and meta-analysisAJOG Global Reports at a Glance
AJOG Global Reports
assisted reproductive technology
hysteroscopy
infertility
in vitro fertilization
title Effect of the decision to perform hysteroscopy on asymptomatic patients before undergoing assisted reproduction technologies—a systematic review and meta-analysisAJOG Global Reports at a Glance
title_full Effect of the decision to perform hysteroscopy on asymptomatic patients before undergoing assisted reproduction technologies—a systematic review and meta-analysisAJOG Global Reports at a Glance
title_fullStr Effect of the decision to perform hysteroscopy on asymptomatic patients before undergoing assisted reproduction technologies—a systematic review and meta-analysisAJOG Global Reports at a Glance
title_full_unstemmed Effect of the decision to perform hysteroscopy on asymptomatic patients before undergoing assisted reproduction technologies—a systematic review and meta-analysisAJOG Global Reports at a Glance
title_short Effect of the decision to perform hysteroscopy on asymptomatic patients before undergoing assisted reproduction technologies—a systematic review and meta-analysisAJOG Global Reports at a Glance
title_sort effect of the decision to perform hysteroscopy on asymptomatic patients before undergoing assisted reproduction technologies a systematic review and meta analysisajog global reports at a glance
topic assisted reproductive technology
hysteroscopy
infertility
in vitro fertilization
url http://www.sciencedirect.com/science/article/pii/S2666577823000199
work_keys_str_mv AT gregjmarchandmdfacsficsfacog effectofthedecisiontoperformhysteroscopyonasymptomaticpatientsbeforeundergoingassistedreproductiontechnologiesasystematicreviewandmetaanalysisajogglobalreportsataglance
AT ahmedtahermasoudmd effectofthedecisiontoperformhysteroscopyonasymptomaticpatientsbeforeundergoingassistedreproductiontechnologiesasystematicreviewandmetaanalysisajogglobalreportsataglance
AT hollieulibarribs effectofthedecisiontoperformhysteroscopyonasymptomaticpatientsbeforeundergoingassistedreproductiontechnologiesasystematicreviewandmetaanalysisajogglobalreportsataglance
AT juliaparisebs effectofthedecisiontoperformhysteroscopyonasymptomaticpatientsbeforeundergoingassistedreproductiontechnologiesasystematicreviewandmetaanalysisajogglobalreportsataglance
AT amandaarroyobs effectofthedecisiontoperformhysteroscopyonasymptomaticpatientsbeforeundergoingassistedreproductiontechnologiesasystematicreviewandmetaanalysisajogglobalreportsataglance
AT catherinecoriellbs effectofthedecisiontoperformhysteroscopyonasymptomaticpatientsbeforeundergoingassistedreproductiontechnologiesasystematicreviewandmetaanalysisajogglobalreportsataglance
AT sydneegoetzbs effectofthedecisiontoperformhysteroscopyonasymptomaticpatientsbeforeundergoingassistedreproductiontechnologiesasystematicreviewandmetaanalysisajogglobalreportsataglance
AT carmenmoirbs effectofthedecisiontoperformhysteroscopyonasymptomaticpatientsbeforeundergoingassistedreproductiontechnologiesasystematicreviewandmetaanalysisajogglobalreportsataglance
AT atleymoberlybs effectofthedecisiontoperformhysteroscopyonasymptomaticpatientsbeforeundergoingassistedreproductiontechnologiesasystematicreviewandmetaanalysisajogglobalreportsataglance